The domestically developed test kits have been actively exported to overseas countries. And it has accelerated the advancement of the domestic companies into the global medical market. Therefore, a lot of companies have focused efforts into increasing the speed of diagnosis, in order to strengthen their competitiveness. ABSOLOGY is a company that develops and mass-produces in vitro diagnostic medical devices. ABSOL, which is an in-vitro-diagnostic immunoassay system, is one of the main items of the company. The system consists of an analyzing device and a test kit. And it only takes about 5-30 minutes to check the test result. Moreover, it is possible to test multiple elements only with a single device. The company has also developed ABSOL HS which is a device for high-sensitive quantitative immunodiagnosis. Unlike the existing ABSOL products, it can analyze even the minimum amount of biomarkers with increased level of sensitivity. What is more, the firm has established a system for mass production by introducing automation facilities. And it aims to grow as a global business. We introduce ABSOLOGY, which has developed in vitro diagnostic systems with increased speed and accuracy.